Review article: Pathogenesis of helicobacter pylori-induced gastric inflammation

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 9, 2001, Pages 1271-1290

  Israel, D A ^a   Peek, R M ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; ANTIGEN; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; UREASE;

BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CAG ISLAND; CANCER RISK; CPG ISLAND; DISEASE PREDISPOSITION; ERADICATION THERAPY; GASTRITIS; GENOTYPE; HELICOBACTER PYLORI; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFECTION RISK; INFLAMMATION; PATHOGENESIS; PEPTIC ULCER; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STOMACH CANCER; STRAIN DIFFERENCE; ADENOCARCINOMA; ANTIBODY PRODUCTION; GENETICS; HELICOBACTER INFECTION; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; STOMACH TUMOR;

ADENOCARCINOMA; ANTIBODY FORMATION; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; STOMACH NEOPLASMS;

EID: 0035462919     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.01052.x     Document Type: Review

References (228)

1. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration
2. Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb. nov. & Helicobacter mustelae comb. nov., respectively
3. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons
4. Helicobacter pylori and peptic ulcer disease
5. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii
6. Helicobacter pylori infection and the risk of gastric carcinoma
7. Helicobacter pylori infection and gastric lymphoma
8. Human gastric carcinogenesis: A multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention
9. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis
10. Decreased prevalence of Helicobacter pylori infection in gastroesophageal reflux disease
11. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease
12. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma
13. Role of Helicobacter pylori cagA (+) strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia
14. Colonization with cagA-positive Helicobacter pylori strains inversely associated with reflux esophagitis and Barrett's esophagus
15. Helicobacter pylori is not associated with the manifestations of gastroesophageal reflux disease
16. The incidence of reflux oesophagitis after cure of Helicobacter pylori in a Japanese population
17. Curing Helicobacter pylori infection in patients with duodenal ulcer does not provoke gastroesophageal reflux disease
18. Helicobacter pylori and gastroesophageal reflux disease: Lack of influence of infection on twenty-four hour esophageal pH monitoring and endoscopic findings
19. Attempt to fulfill Koch's postulates for pyloric Campylobacter
20. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH
21. Campylobacter pylori and duodenal ulcers: The gastrin link
22. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease
23. Helicobacter pylori and gastric acid: Biological and therapeutic implications
24. Nucleotide sequence of two genes from Helicobacter pylori encoding for urease subunits
25. Purification and characterization of urease from Helicobacter pylori
26. Shuttle cloning and nucleotide sequences of Helicobacter pylori genes responsible for urease activity
27. Molecular biology of microbial ureases
28. Investigation of the structure and localization of the urease of Helicobacter pylori using monoclonal antibodies
29. Influence of pH on metabolism and urease activity of Helicobacter pylori
30. Expression of the Helicobacter pylori ureI gene is required for acidic pH activation of cytoplasmic urease
31. +-gated urea channel: The link between Helicobacter pylori urease and gastric colonization
32. The Helicobacter pylori UreI protein is not involved in urease activity but is essential for bacterial survival in vivo
33. Effect of gastric pH on urease-dependent colonization of gnotobiotic piglets by Helicobacter pylori
34. Characterization of the Helicobacter pylori urease and purification of its subunits
35. Determinants of Helicobacter pylori pathogenicity
36. Cloning and genetic characterization of a Helicobacter pylori flagellin gene
37. Colonization of gnotobiotic piglets by Helicobacter pylori deficient in two flagellin genes
38. Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis
39. Gastric epithelium in the duodenum: Its association with Helicobacter pylori and inflammation
40. Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori
41. The glycerolipid receptor for Helicobacter pylori (and exoenzyme S) is phosphatidy-lethanolamine
42. Receptor affinity purification of a lipid-binding adhesin from Helicobacter pylori
43. Helicobacter mustelae and Helicobacter pylori bind to common lipid receptors in vitro
44. Adherence of Helicobacter pylori cells and their surface components to HeLa cell membranes
45. High-affinity binding of the basement membrane proteins collagen type IV and laminin to the gastric pathogen Helicobacter pylori
46. High-affinity binding of laminin by Helicobacter pylori: Evidence for a lectin-like interaction
47. Affinity of the gastric pathogen Helicobacter pylori for the N-sulphated glycosaminoglycan heparan sulphate
48. Identification of glycolipid receptors for Helicobacter pylori by TLC-immuno-staining
49. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin
50. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging
51. The complete genome sequence of the gastric pathogen Helicobacter pylori
52. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
53. Epithelial attachment alters the outcome of Helicobacter pylori infection
54. Conservation, localization and expression of HopZ, a protein involved in adhesion of Helicobacter pylori
55. Genetic and functional characterization of the alpAB gene locus essential for the adhesion of Helicobacter pylori to human gastric tissue
56. Lipopolysaccharide structures of Helicobacter pylori genomic strains 26695 and J99, mouse model H. pylori Sydney strain, H. pylori P466 carrying sialyl Lewis X, and H. pylori UA915 expressing Lewis B classification of H. pylori lipopolysaccharides into glycotype families
57. Mimicry of blood group antigen A by Helicobacter mustelae and H. pylori
58. Expression of histo-blood group antigens by lipopolysaccharides of Helicobacter pylori strains from Asian hosts; the propensity to express type 1 blood-group antigens
59. Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. Molecular mimicry between H. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms
60. Functional genomics of Helicobacter pylori: Identification of a beta-1, 4 galactosyltransferase and generation of mutants with altered lipopolysaccharide
61. Why Helicobacter pylori has Lewis antigens
62. Helicobacter pylori Lewis expression is related to the host Lewis phenotype
63. Association of peptic ulcer with increased expression of Lewis antigens but not cagA, iceA, and vacA in Helicobacter pylori isolates in an Asian population
64. The lipopolysaccharide of Helicobacter mustelae type strain ATCC 43772 expresses the monofucosyl A type 1 histo-blood group epitope
65. Molecular mimicry of ferret gastric epithelial blood group antigen A by Helicobacter mustelae
66. Relationship of blood group determinants on Helicobacter pylori lipopolysaccharide with host Lewis phenotype and inflammatory response
67. Lack of correlation between Lewis antigen expression by Helicobacter pylori and gastric epithelial cells in infected patients
68. Phenotypic diversity in Lewis expression of Helicobacter pylori isolates from the same host
69. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity
70. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa
71. Antigastric autoantibodies in Helicobacter pylori infection: Implications of histological and clinical parameters of gastritis
72. +-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy
73. Anti-Lewis X IgM and IgG in H. pylori infections in children and adults
74. Establishment and characterisation of a monoclonal antibody to inhibit adhesion of Helicobacter pylori to gastric epithelial cells
75. H. pylori and Lewis antigens
76. Phase variation in Helicobacter pylori lipopolysaccharide
77. Phase variation in Helicobacter pylori lipopolysaccharide due to changes in the lengths of poly (C) tracts in alpha3-fucosyltransferase genes
78. Molecular genetic basis for the variable expression of Lewis Y antigen in Helicobacter pylori: Analysis of the alpha (1, 2) fucosyltransferase gene
79. Lewis antigens in Helicobacter pylori: Biosynthesis and phase variation
80. Phase variation in H type I and Lewis a epitopes of Helicobacter pylori lipopolysaccharide
81. Campylobacter pyloridis, gastritis, and peptic ulceration
82. Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa
83. Immunobiological activities of Helicobacter pylori porins
84. Paf-acether synthesis by Helicobacter pylori
85. Mechanisms involved in Helicobacter pylori-induced inflammation
86. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis
87. Interferon-gamma and tumour necrosis factor production in patients with Helicobacter pylori infection
88. Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection
89. + Helicobacter pylori strains
90. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa
91. Transepithelial signaling to neutrophils by salmonellae: A novel virulence mechanism for gastroenteritis
92. Apical secretion of a pathogen-elicited epithelial chemoattractant activity in response to surface colonization of intestinal epithelia by Salmonella typhimurium
93. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa
94. Helicobacter pylori induced interleukin-8 expression in gastric epithelial ceils is associated with CagA positive phenotype
95. Expression of interleukin-8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro
96. Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro
97. Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45
98. IKK-1 and IKK-2: Cytokine-activated IkappaB kinases essential for NF-kappaB activation
99. Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells
100. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells
101. H. pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells
102. Signal transduction by the c-June N-terminal kinase (JNK) - From inflammation to development
103. Organization and regulation of mitogen-activated protein kinase signaling pathways
104. Mitogen-activated protein kinases: Specific messages from ubiquitous messengers
105. Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cag- Helicobacter pylori
106. Activation of activator protein 1 and stress response kinases in epithelial cells colonized by Helicobacter pylori encoding the cag pathogenicity island
107. Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun
108. Characterization of a Helicobacter pylori neutrophil-activating protein
109. The Helicobacter pylori neutrophil-activating protein is an iron-binding protein with dodecameric structure
110. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor
111. N-acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: A putative colonization factor antigen
112. Campylobacter pylori antibodies in humans
113. Mucosal humoral immune response to Helicobacter pylori in patients with duodenitis
114. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity
115. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology
116. A sensitive and specific serologic test for detection of Campylobacter pylori infection
117. Opsonic activity of specific human IgC against Helicobacter pylori
118. Susceptibility of Helicobacter pylori to the bactericidal activity of human serum
119. Human monoclonal antibodies from stomach carcinoma patients react with Helicobacter pylori and stimulate stomach cancer cells in vitro
120. Virulence and pathogenicity of Helicobacter pylori
121. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype
122. Differential stimulation of interleukin-12 (IL-12) and IL-1O by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa
123. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model
124. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice
125. Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice
126. Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis
127. Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load
128. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy
129. Nonopsonic activation of neutrophils and cytotoxin production by Helicobacter pylori: Ulcerogenic markers
130. Association of cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis
131. Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa
132. Oxidative DNA damage accumulation in gastric carcinogenesis
133. Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation
134. Helicobacter pylori and cell proliferation of the gastric mucosa: Possible implications for gastric carcinogenesis
135. Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis
136. Induction of gastric epithelial apoptosis by Helicobacter pylori
137. The molecular biology of apoptosis
138. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: Effect of antibiotics and antioxidants
139. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection
140. Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis
141. Regulation of gastric epithelial cell growth by Helicobacter pylori: Evidence for a major role of apoptosis
142. Helicobacter pylori modulates lymphoepithelial cell interactions leading to epithelial cell damage through Fas/Fas ligand interactions
143. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis
144. Therapeutic opportunities from the pharmacological manipulation of the Fas system
145. Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression
146. Apoptosis in Helicobacter pylori-associated gastric and duodenal ulcer disease is mediated via the Fas antigen pathway
147. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease
148. Tumor necrosis factor alpha and interleukin 1beta up-regulate gastric mucosal Fas antigen expression in Helicobacter pylori infection
149. Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter felis infection
150. Association of Campylobacter pylori with induced expression of class II transplantation antigens on gastric epithelial cells
151. HLA class II signaling mediates cellular activation and programmed cell death
152. The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: A mechanism for T helper cell type 1-mediated damage
153. Helicobacter pylori urease binds to class II MHC on gastric epithelial cells and induces their apoptosis
154. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
155. Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis
156. Increased gastric epithelial cell apoptosis associated with colonization with cagA+ Helicobacter pylori strains
157. Helicobacter pylori strain-specific genotypes and modulation of the gastric epithelial cell cycle
158. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release
159. Quasispecies development of Helicobacter pylori observed in paired isolates obtained years apart from the same host
160. Expanding allelic diversity of Helicobacter pylori vacA
161. Recombination and clonal groupings within Helicobacter pylori from different geographical regions
162. PCR-based RFLP analysis of DNA sequence diversity in the gastric pathogen Helicobacter pylori
163. Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: Extensive allelic diversity and recombinational population structure
164. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori
165. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: Studies in four different countries
166. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer
167. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: Evidence of linkage to cytotoxin production
168. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors
169. Analyses of the cag pathogenicity island of Helicobacter pylori
170. Detection of Helicobacter pylori gene expression in human gastric mucosa
171. Helicobacter pylori and atrophic gastritis: Importance of the cagA status
172. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer
173. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach
174. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection
175. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma
176. cagA-positive Helicobacter pylori and risk for developing gastric carcinoma in Brazil
177. Infection with CagA+ Helicobacter pylori strains as a possible predictor of risk in the development of gastric adenocarcinoma in Mexico
178. CagA protein seropositivity in a random sample of adult population and gastric cancer patients in Estonia
179. CagA seropositivity associated with development of gastric cancer in a Japanese population
180. A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains
181. Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses
182. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion
183. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation
184. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells
185. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells
186. Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF-kappaB activation
187. Altered states: Involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori
188. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines
189. Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbils
190. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori
191. Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori
192. Purification and characterization of the vacuolating toxin from Helicobacter pylori
193. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains
194. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease
195. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: Structural similarities with the IgA protease type of exported protein
196. Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori
197. Oligomeric and subunit structure of the Helicobacter pylori vacuolating cytotoxin
198. Acid-induced dissociation of VacA, the Helicobacter pylori vacuolating cytotoxin reveals its pattern of assembly
199. Structure and interaction of VacA of Helicobacter pylori with a lipid membrane
200. The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH
201. Inhibition of the vacuolating and anion channel activities of the VacA toxin of Helicobacter pylori
202. VacA from Helicobacter pylori: A hexameric chloride channel
203. Acid activation of Helicobacter pylori vacuolating cytotoxin (VacA) results in toxin internalization by eukaryotic cells
204. Potentiation of Helicobacter pylori vacuolating toxin activity by nicotine and other weak bases
205. Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments
206. Vacuoles induced by Helicobacter pylori toxin contain both late endosomal and lysosomal markers
207. Helicobacter pylori vacuolating toxin accumulates within the endosomal - Vacuolar compartment of cultured gastric cells and potentiates the vacuolating activity of ammonia
208. Persistence of Helicobacter pylori VacA toxin and vacuolating potential in cultured gastric epithelial cells
209. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration
210. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori
211. The Helicobacter pylort vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany
212. The significance of cagA and vacA subtypes of Helicobacter pylori in the pathogenesis of inflammation and peptic ulceration
213. Helicobacter pylori cagA status, vacA genotypes and ulcer disease
214. Geographic distribution of vacA allelic types of Helicobacter pylori
215. Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease
216. Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome
217. Molecular cloning and expression of NlaIII restriction-modification system in E. coli
218. Genetic organization and heterogeneity of the iceA locus of Helicobacter pylori
219. Quantitative detection of Helicobacter pylori gene expression in vivo and relationship to gastric pathology
220. Isolation of a Helicobacter pylori protein, FldA, associated with mucosa-associated lymphoid tissue lymphoma of the stomach
221. High seropositivity of anti-CagA antibody in Helicobacter pylori-infected patients irrelevant to peptic ulcers and normal mucosa in Japan
222. Sequence analysis and clinical significance of the iceA gene from Helicobacter pylori strains in Japan
223. Helicobacter pylori physiology predicted from genomic comparison of two strains
224. A M(r) 34 000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori
225. Modulation of Helicobacter pylori induced interleukin-8 synthesis in gastric epithelial cells mediated by cag PAI encoded VirD4 homologue
226. Gastric mucosal secretion of interleukin-10: Relations to histopathology, Helicobacter pylori status, and tumour necrosis factor-alpha secretion
227. Activation of human THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide
228. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination